ザルトリウス・ステディム・ジャパン List of News Articles

Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. Sartorius has developed CHO cell lines for over 300 projects, with 7 projects approved and more than 80 in clinical trials. The projects include IgG1, 2, 4, multi-specific antibodies, Fc fusion proteins, enzymes, hormones, new drugs, and biosimilars. Our customers range from large companies to startups, with over 70% of them being repeat clients. In this webinar, we will introduce the details of our flexible and comprehensive services, including CHO cell line development, MCB/WCB manufacturing and testing, molecular characterization, FUT8 Knock Out, provision of optimized media, and process enhancement. *We sincerely apologize, but we kindly ask that participants refrain from joining with email addresses other than those from your company or organization. Thank you for your understanding.

We will be exhibiting and presenting a seminar at TIDES Asia 2025, which will be held in Kyoto from February 26 to 28, 2025. TIDES Asia is the leading conference in Asia that gathers experts in oligonucleotides, peptides, mRNA, and genome editing therapeutics. At this conference, we plan to showcase high-throughput TFF equipment for parallel screening and hold a seminar on innovative solutions for peptide therapeutic manufacturing. We look forward to your visit. 【Event Overview】 Date: February 26 (Wednesday) - 27 (Friday), 2025 Location: The Westin Miyako Hotel Kyoto *Pre-registration required 【Our Seminar】 Title: Fit for Future: Advancing Bioprocess Manufacturing by Identifying Top Performing Clones and Enhancing Productivity through Process Intensification Seminar Date and Time: 27th (Thursday) at 15:45

To maximize the performance of CHO cells, it is necessary to select the optimal medium for each clone and further optimize the process parameters. Sartorius offers a variety of basic media and feeds suitable for Fed-batch culture of major CHO cell lines such as CHO-DG44, K1, S, and GS. In this webinar, we will introduce a case study that combines these CHO media, the automated microbioreactor Ambr15, and the experimental design software MODDE to conduct medium screening and process optimization in a short period. We will also provide information about our Benchmark Study service, which allows you to outsource the selection of the optimal medium and process development for your specific cell line to our research institute in Germany. 【Seminar Overview】 ▪ Date: March 6, 2025 (Thursday) from 3:00 PM (approximately 40 minutes) ▪ Method: Webinar recorded broadcast [Japanese, Free] If you are unable to participate on the day, please register first. We will send you a viewing URL later. *We kindly ask that participants from other companies in the same industry, as well as those using email addresses not affiliated with your organization, refrain from joining. Thank you for your understanding.

In the pharmaceutical and biopharmaceutical industry, there is an increasing need to maintain world-class quality and adopt the latest technologies to enhance technical skills and productivity. The biggest challenge faced is responding to new compliance measures and regulations. At Sartorius, we have prepared training courses focused on practical exercises, aimed at enabling our customers to perform their work safely and efficiently. The courses listed can also be customized to meet your specific needs. If necessary, they can be held remotely. You can apply using the "Dedicated Form" on page 11 of the "Related Materials" or through the "Related Links." You can check the schedule from the "Related Materials." We look forward to your participation in Sartorius training.